Epipens. The company said it would not be able to meet the demand for its product in time and that some patients may have to wait until next year. Tysabri. Same with the U&C price on drugs, except there’s no back office for consumers to negotiate with. Acthar. Harvoni. Every month, it seems, there’s fresh outrage–from president Trump, the Congress, in the media, and among the public–over the soaring cost of prescription drugs.
Epipens. The company said it would not be able to meet the demand for its product in time and that some patients may have to wait until next year. Tysabri. Acthar. Harvoni. Every month, it seems, there’s fresh outrage–from president Trump, the Congress, in the media, and among the public–over the soaring cost of prescription drugs.